Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-27 @ 8:14 AM
Study NCT ID:
NCT00945269
Status:
TERMINATED
Last Update Posted:
2022-11-15
First Post:
2009-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-23
First Submit QC Date:
None
Study First Post Date:
2009-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-12-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-11-10
Last Update Post Date:
2022-11-15
Last Update Post Date Type:
ACTUAL